Astellas Pharma Inc. ADR (ALPMY): Price and Financial Metrics


Astellas Pharma Inc. ADR (ALPMY): $16.42

-0.13 (-0.79%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ALPMY Stock Price Chart Interactive Chart >

Price chart for ALPMY

ALPMY Price/Volume Stats

Current price $16.42 52-week high $18.46
Prev. close $16.55 52-week low $13.41
Day low $16.27 Volume 37,600
Day high $16.48 Avg. volume 69,802
50-day MA $17.17 Dividend yield 1.7%
200-day MA $15.92 Market Cap 30.57B

Astellas Pharma Inc. ADR (ALPMY) Company Bio


Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.


ALPMY Latest News Stream


Event/Time News Detail
Loading, please wait...

ALPMY Latest Social Stream


Loading social stream, please wait...

View Full ALPMY Social Stream

ALPMY Price Returns

1-mo -4.76%
3-mo 8.20%
6-mo -0.82%
1-year 3.13%
3-year 6.02%
5-year 0.14%
YTD 7.27%
2020 -7.64%
2019 37.34%
2018 0.64%
2017 -8.51%
2016 -3.14%

ALPMY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ALPMY Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7773 seconds.